Current Cardiology Reviews
Title:Meet Our Editorial Board Member
Volume: 13 Issue: 4
Author(s): Lloyd W. Klein
Affiliation:
Export Options
About this article
Cite this article as:
Klein W. Lloyd , Meet Our Editorial Board Member, Current Cardiology Reviews 2017; 13 (4) . https://dx.doi.org/10.2174/1573403X1304171023124658
DOI https://dx.doi.org/10.2174/1573403X1304171023124658 |
Print ISSN 1573-403X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6557 |
Related Journals
Related Books
14
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Effect of TNFα-Inhibitors on Cardiovascular Events in Patients with Rheumatoid Arthritis: An Updated Systematic Review of the Literature
Current Rheumatology Reviews Cardiovascular Effects of Endogenous Estrogen and Hormone Therapy
Current Vascular Pharmacology New Approaches for the Treatment of Chagas Disease
Current Drug Targets Bone: A Fertile Soil for Cancer Metastasis
Current Drug Targets Mast Cell – Glia Dialogue in Chronic Pain and Neuropathic Pain: Blood-Brain Barrier Implications
CNS & Neurological Disorders - Drug Targets Interleukin-18, From Neuroinflammation to Alzheimers Disease
Current Pharmaceutical Design Withdrawal Notice: Electrophoresis as a Tool for Early Cancer Diagnosis
Anti-Cancer Agents in Medicinal Chemistry Systemic Adverse Drug Reactions Secondary to Anti-VEGF Intravitreal Injection in Patients with Neovascular Age-Related Macular Degeneration
Current Vascular Pharmacology Role of Advanced Glycation End Products (AGEs) in Thrombogenic Abnormalities in Diabetes
Current Neurovascular Research Cognitive Decline as a Consequence of Essential Hypertension
Current Pharmaceutical Design Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors to Reduce Cardiovascular Inflammation and Outcomes
Current Medicinal Chemistry Study about the Effect of System Parameters on the Dynamic Properties of Hydraulic Buffer System Applied to Belt Arrestor for Downward Belt Conveyor
Recent Patents on Mechanical Engineering The Importance of Gender Differences in the Diagnosis and Management of Cardiovascular Disease
Current Pharmaceutical Design Absorption, Disposition and Pharmacokinetic Properties of Novel Therapeutic Modalities (Part II)
Current Drug Metabolism Rivaroxaban versus Clopidogrel for Peripheral Artery Disease: A Clinico-Economic Approach of the COMPASS Trial
Current Pharmaceutical Design Prolylcarboxypeptidase Gene Expression in the Heart and Kidney: Effects of Obesity and Diabetes
Cardiovascular & Hematological Agents in Medicinal Chemistry Mechanisms Explaining the Influence of Subclinical Hypothyroidism on the Onset and Progression of Chronic Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets Phytochemical and Pharmacological Activity Profile of Crataegus oxyacantha L. (Hawthorn) - A Cardiotonic Herb
Current Medicinal Chemistry The Roles of Cytochrome P450 in Ischemic Heart Disease
Current Drug Metabolism Oxytocin as a Potential Adjuvant Against COVID-19 Infection
Endocrine, Metabolic & Immune Disorders - Drug Targets